Outset Tablo is FDA-approved for Home Hemodialysis
Last week, the FDA expanded approval of the Tablo hemodialysis machine to home use—just in time to offer a new option for COVID-19 related challenges. The intuitive, easy to learn system requires little set-up time. Outset’s next step will be a controlled rollout at select sites.
Read the full article » | Posted 04-13-2020
Related Articles
- In August 2026, 70 nephrology fellows were chosen for the 2026–2027 ASN Home Dialysis Scholarship Program Posted 09-18-2026
- Dialysis Act would give patients more stability, options, Atlanta Journal-Constitution, August 28, 2026 Posted 09-18-2026
- NKF Survey Sheds Light on Work Responsibilities and More Posted 07-16-2026
- Home HD Now Offered in Croatia Posted 07-16-2026

